How should blood‑pressure fluctuations (intradialytic hypotension and interdialytic hypertension) be managed in a patient receiving hemodialysis?

Management of Blood Pressure Fluctuations in Dialysis Patients

Immediate Recognition and Assessment

When blood pressure fluctuations occur during hemodialysis, immediately distinguish between intradialytic hypotension (nadir SBP <90 mmHg or symptomatic drops) and intradialytic hypertension (SBP rise >10 mmHg pre- to post-dialysis), because these two patterns require opposite management strategies and both independently increase mortality risk. 1, 2

Define the Pattern

• Intradialytic hypotension occurs when SBP drops below 90 mmHg or when any symptomatic decrease requires intervention (saline bolus, ultrafiltration reduction, or blood pump flow reduction). 1
• Intradialytic hypertension is defined as SBP increase >10 mmHg from pre- to post-dialysis, particularly when this pattern occurs in at least 4 of 6 consecutive treatments. 1, 2
• Both patterns affect 5-15% of hemodialysis patients and carry mortality risk comparable to severe cardiovascular events. 2, 3

Obtain Out-of-Unit Blood Pressure Measurements

• Immediately initiate home blood pressure monitoring (twice daily for 4 days following midweek treatment) or 44-hour ambulatory blood pressure monitoring, because in-center measurements correlate poorly with true interdialytic blood pressure burden and have either no association or U/J-shaped associations with mortality. 2, 4
• Pre- and post-dialysis measurements alone are imprecise estimates of interdialytic blood pressure and should not guide long-term management decisions. 4

---

Management of Intradialytic Hypotension

During the Dialysis Session

• Continue ultrafiltration at reduced rates (<6 mL/kg/hr) rather than stopping dialysis entirely, unless severe cramping unresponsive to rate reduction, clinical evidence of acute volume depletion, or other acute complications develop. 2, 5
• Increase blood pressure monitoring frequency to every 30-60 minutes in patients experiencing hypotensive episodes or requiring vasopressor support to maintain mean arterial pressure ≥65 mmHg. 4
• Administer saline boluses promptly when symptomatic hypotension occurs (abdominal discomfort, yawning, nausea, muscle cramps, dizziness, or anxiety). 4, 5

Post-Session Management Algorithm

• Reassess dry weight estimation at the next session, because incorrect target weight is the most common correctable cause of recurrent intradialytic hypotension. 5
• Minimize interdialytic weight gains through dietary sodium restriction (2-3 g/day) with regular dietitian counseling, reducing the ultrafiltration burden at subsequent sessions. 2, 5
• Consider longer or more frequent dialysis sessions (≥5 hours per session) to achieve adequate volume removal without excessive ultrafiltration rates that trigger hypotension. 2, 5

Medication Adjustments

• Review and adjust timing of antihypertensive medications, avoiding administration immediately before dialysis when blood pressure naturally declines. 6
• Reduce or discontinue highly dialyzable antihypertensives (atenolol, metoprolol) that are removed during the session and cannot provide intradialytic protection. 2

Critical Pitfall to Avoid

• Do not measure blood pressure immediately after needle insertion, as this causes stress-induced elevation that does not reflect true blood pressure status and will lead to incorrect dry weight assessment. 4

---

Management of Intradialytic Hypertension

During the Dialysis Session

• Continue ultrafiltration to achieve the prescribed dry weight target, because volume removal remains the cornerstone of management even when blood pressure rises during dialysis. 2
• Do not reduce ultrafiltration rate unless signs of acute volume depletion appear (severe cramping, symptomatic hypotension upon standing, clinical hypovolemia). 2

Post-Session Algorithmic Management

Step 1: Aggressive Dry Weight Reduction

• Challenge and reduce dry weight over 4-12 weeks (potentially 6-12 months for patients with diabetes or cardiomyopathy), because volume overload is the primary driver of intradialytic hypertension and blood pressure may continue to decrease for 8 months or longer after extracellular fluid volume normalizes. 2, 7
• The relationship between extracellular fluid volume and systolic blood pressure is sigmoidal rather than linear, so blood pressure rises sharply only after the patient's autoregulatory capacity is exceeded. 2
• Do not stop the dry weight probing process prematurely based on isolated blood pressure readings. 2

Step 2: Dialysate and Session Modifications

• Lower dialysate sodium concentration to reduce interdialytic fluid accumulation and allow more effective volume control. 2, 7
• Consider longer or more frequent dialysis sessions to achieve better volume control without excessive ultrafiltration rates. 2

Step 3: Dietary Sodium Restriction

• Implement strict dietary sodium restriction (2-3 g/day) with regular counseling by dietitians to reduce interdialytic fluid accumulation. 2

Step 4: Medication Optimization

• Prioritize nondialyzable antihypertensive agents, particularly beta-blockers with vasodilatory properties such as carvedilol, which demonstrated lower risk of death and cardiovascular death versus placebo in hemodialysis patients with dilated cardiomyopathy. 1, 2, 7
• Add ACE inhibitors or angiotensin receptor blockers to inhibit the renin-angiotensin-aldosterone system, as these agents may reduce left ventricular mass index and preserve residual kidney function, especially in patients with remaining urine output. 1, 2
• Consider amlodipine, which reduced cardiovascular events compared with placebo in hypertensive hemodialysis patients and provides sustained vasodilation to mitigate resistance-mediated blood pressure rise. 1, 2
• Avoid highly dialyzable agents (atenolol, metoprolol) that are removed during dialysis and cannot maintain intradialytic protection. 2
• Administer antihypertensive medications preferentially at night to reduce nocturnal blood pressure surge and minimize intradialytic hypotension risk. 2

Evidence-Based Medication Selection

• Carvedilol is the preferred beta-blocker because it is minimally removed by dialysis and reduces cardiovascular mortality in hemodialysis patients, making it optimal for counteracting the vascular-resistance surge seen with intradialytic hypertension. 1, 2
• Atenolol showed fewer heart failure hospitalizations compared to lisinopril in hemodialysis patients with hypertension and left ventricular hypertrophy, but its dialyzability limits intradialytic protection. 1
• Diuretics may help preserve residual diuresis in patients with remaining kidney function but should not be considered primary antihypertensive medication in the dialysis setting, as they have minimal effect on central hemodynamic indices. 1

Monitoring and Follow-Up

• Reassess blood pressure response after each intervention using both dialysis unit measurements and out-of-unit monitoring (home or ambulatory). 2
• Continue dry weight challenges until the intradialytic blood pressure pattern normalizes or clinical signs of volume depletion appear. 2
• Evaluate blood pressure patterns over time rather than isolated readings, monitoring for both hypotensive and hypertensive episodes during and after dialysis. 3

---

Technical Requirements for Accurate Blood Pressure Measurement

Minimum Required Measurements

• Measure blood pressure at least twice per dialysis session: once before dialysis (at least 5 minutes before needle insertion) and once at the end of dialysis, with both seated and standing measurements at each timepoint. 4
• Patients must be seated quietly for at least 5 minutes with feet flat on floor and arm supported at heart level before measurement. 4
• Standing blood pressure should be obtained after at least 2 minutes upright with arm supported at heart level to detect orthostatic hypotension (fall ≥15 mmHg systolic and ≥10 mmHg diastolic). 4

Technical Specifications

• Use auscultatory method with Korotkoff sounds for diastolic blood pressure, appropriate cuff size with bladder encircling at least 80% of arm circumference. 4
• Avoid caffeine, exercise, and smoking for at least 30 minutes before measurement. 4
• Regularly inspect and validate equipment, as automated devices can overestimate blood pressure by 14/7 mmHg. 4

Common Pitfalls to Avoid

• Do not rely solely on isolated pre- or post-dialysis readings, as they correlate poorly with interdialytic ambulatory blood pressure and have substantial day-to-day variability. 4
• Do not skip standing measurements in elderly patients or those with diabetes, as these populations have the highest risk of autonomic dysfunction and orthostatic hypotension. 4
• Do not use automated devices without validation, as they systematically overestimate blood pressure in dialysis patients. 4

---

Pathophysiologic Mechanisms Underlying Blood Pressure Fluctuations

Intradialytic Hypotension Mechanisms

• Ultrafiltration rate that surpasses mechanisms activated to avert a decline in blood pressure is the fundamental cause. 6, 5
• Inadequate vascular refill, suboptimal vascular response compromising the ability to compensate for acute intravascular volume loss, and incorrect assessment of target weight contribute. 5
• Patient-related factors include age, comorbidities (especially cardiac disease and autonomic dysfunction), and acute illnesses. 6, 5

Intradialytic Hypertension Mechanisms

• Volume overload is the major factor, with patients demonstrating chronic extracellular volume overload compared to other hemodialysis patients. 7, 8
• Acute intradialytic vascular resistance surges likely explain the blood pressure increase during dialysis, possibly mediated by endothelial cell dysfunction. 7, 8
• Sympathetic nervous system overactivity, renin-angiotensin-aldosterone system activation, arterial stiffness, and dialysate-to-serum sodium gradients also contribute. 2, 7

---

When to Consider Hospital Admission or Defer Discharge

• Admit or defer discharge if signs of hypertensive emergency develop (chest pain, dyspnea, altered mental status, visual disturbances), because these indicate urgent blood pressure control is needed. 4
• Do not discharge patients exhibiting symptomatic orthostatic hypotension without further evaluation. 4
• Recognize that rapid reduction of blood pressure in dialysis patients can precipitate hypotension and adverse cardiovascular events; aggressive lowering should be avoided in the emergency setting. 4